Modified method of AgNOR staining for tissue and interpretation in histopathology

International Journal of Experimental Pathology

Volumn 88, Issue 1, 2007, Pages 47-53

  Bukhari, Mulazim Hussain ^a   Niazi, Shahida ^a   Khan, Saeed Akhter ^a   Hashmi, Ihsanulla ^a   Perveen, Shahida ^a   Qureshi, Shahzad Shafqat ^a   Chaudhry, Naseer Ahmed ^a   Qureshi, G R ^a   Hasan, Mumtaz ^a  

^a KING EDWARD MEDICAL UNIVERSITY   (Pakistan)

Author keywords

AgNOR; Astrocytoma; Astrogliosis; Glioblastoma multiform; Gold chloride; Neutral red; Sodium thiosulphate

Indexed keywords

ARTICLE; ASTROCYTOMA; BRAIN DAMAGE; BRAIN TISSUE; CELL ACTIVITY; CELL PROLIFERATION; CHROMOSOME NOR; CONTROLLED STUDY; DISPERSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RELIABILITY; SILVER STAINING; STATISTICAL SIGNIFICANCE;

ANTIGENS, NUCLEAR; ASTROCYTOMA; BIOLOGICAL MARKERS; BRAIN; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL PROLIFERATION; HUMANS; NUCLEAR PROTEINS; PARAFFIN EMBEDDING; SILVER STAINING;

EID: 33846417295     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2006.00522.x     Document Type: Article

References (19)

1. Akhtar G.N., Chaudrhy N.A., Tayyab M., Khan S.A. (2004) AgNOR staining in malignant and benign effusion pak. J. Med. Sci. 20, 29-32.
2. Banacroft J.D. (2002) Cytoplasmic granules, organelles and neuroendocrine. In: Theory and Practice of Histological Techniques, 5th edn, p. 350 (eds J. D. Banacroft, M. Gamble) New Yark: Churchill Livingston.
3. Bankfalvi A.B., Schmitz K., Mock T., Kemper M., Cubick C., Böcker W. (1998) Relationship between AgNOR proteins, Ki-67 antigen, p53 immunophenotype and differentiation markers in archival breast carcinomas. Anal. Cell. Pathol. 17, 231-242.
4. Bukhari M.H., Iqbal A., Iqbal M.N. et al. (2004) Role of bioenergy of specific soil (SiO2) of madina munawra on chemically carcinogenesis in albino mice by protecting mutation of p53. Annals KEMC 10, 236-240.
5. Derenzini M. & Ploton D. (1991) Interphase nucleolar organizer regions in cancer cells. Int. Rev. Exp. Pathol. 32, 150-192.
6. Derenzini M., Pession A., Trerè D. (1990) Quantity of nucleolar silver-stained proteins is related to proliferative activity in cancer cells. Lab. Invest. 63, 137-140.
7. Fonseca L.M. & do Carmo M.A. (2000) do Carmo MAAgNORs in hyperplasia, papilloma and oral squamous cell carcinoma. Braz. Dent. J. 11, 105-110.
8. Gall J.G. & Pardue M.L. (1969) Formation and detection of RNA-DNA hybrid molecules in cytological preparations. Proc. Natl Acad. Sci. U.S.A. 63, 378-383.
9. Hashmi I.U., Bukhari M.H., Tayyab M. et al. (2006) Evaluation of AgNOR in normal brain tissue and astrocytic glioma. Biomedica 22, 41-47.
10. Helpap B., Loesevitz L., Bulatko A. (1994) Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors. Virchows. Arch. 425, 265-269.
11. Khan S.A., Chaudhry N.A., Khalid A.W., Akhtar G.N., Ibne-Rasa S.N. (2006) Patterns of argyrophilic nucleolar organiser regions in pleural and peritoneal effusions. J. Coll. Physicians Surg. Pak. 16, 412-415.
12. Mourad W.A., Connelly J.H., Sembera D.L., Atkinson E.M., Bruner J.M. (1993) The correlation of two argyophilic nucleolar organizer region counting method with bromodeoxyuridine-labeling index: a study of metastatic tumors of the brain. Hum. Pathol. 24, 206-210.
13. Mourad W.A., Vallieres E., Chuen J., Alrobaish A. (1997) Cell kinetics analysis of surgically resected non-small cell carcinoma of the lung using the AgNOR silver stain. Ann. Saudi Med. 17, 161-166.
14. Parveen S., Bukhari M.H., Khan S.A. et al. (2006) AgNOR stain in normal, cirrhotic and carcinomatous liver. Biomedica 22, 59-61.
15. Pich A., Chiusa L., Marmont F., Cappello N., Navone R. (1992) Argyrophilic nucleolar organizer region counts in multiple myeloma: A histopathological study on bone marrow trephine biopsies. Virchows. Arch. 421, 143-147.
16. Pich A., Chiusa L., Comino A., Navone R. (1994) Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas. Virchows. Arch. 424, 143-148.
17. Pich A., Chiusa L., Margaria E. (1995) Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis. Cancer Detect. Prev. 19, 282-291.
18. Ploton D., Menager M., Jeannesson P., Himber G., Pigeon F., Adnett J.J. (1986) Improvement in the staining and the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Hitched J. 18, 5-14.
19. Tomobe M., Shimazui T., Uchida K., Akaza H. (2001) AgNOR count in resting cells (resting NOR) is a new prognostic marker in invasive bladder tumor. Anal. Cell. Pathol.. 2, 193-199.